LA JOLLA PHARMACEUTICAL CO - 10-Q - 20040507 - SIGNATURES
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
La Jolla Pharmaceutical Company
Date: May 7, 2004
/s/ Steven B. Engle
Steven B. Engle
Chairman and Chief Executive Officer
(On behalf of the Registrant)
/s/ Gail A. Sloan
Gail A. Sloan
Vice President of Finance, Controller and Secretary
(As Principal Financial and Accounting Officer)